MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » iRhythm CEO considers costs on the path to profitability

iRhythm CEO considers costs on the path to profitability

By

iRhythm’s Zio cardiac monitoring device
iRhythm’s Zio cardiac monitoring device [Image courtesy of iRhythm]
Fresh off positive reimbursement news for its Zio remote external electrocardiogram monitoring device, the CEO of iRhythm Technologies (NSDQ:IRTC) doesn’t just have revenue on his mind.

iRhythm President and CEO Quentin Blackford — the former Dexcom COO who replaced Mike Coyle in September — said his company will need to keep costs under control as it grows to serve tens of millions and then hundreds of millions of patients in the years ahead.

Get the full story at our sister site, Medical Design & Outsourcing.

More recent news

About Jim Hammerand

Jim Hammerand is the managing editor of Medical Design & Outsourcing. He has more than two decades of journalism experience spanning newspapers, magazines, websites, live events, radio and TV news. For nearly a decade, Hammerand reported and edited business news for American City Business Journals as a reporter and digital editor at the Minneapolis/St. Paul Business Journal and then managing editor of the Puget Sound Business Journal in Seattle. He holds a bachelor’s degree in journalism from the University of Minnesota. He is based near Seattle, Washington, where he and his family live. Connect with him on LinkedIn or by email at [email protected].